X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (100) 100
humans (87) 87
glucose (66) 66
animals (64) 64
diabetes mellitus, type 2 - drug therapy (58) 58
sodium-glucose transporter 2 - antagonists & inhibitors (58) 58
diabetes (57) 57
type 2 diabetes (51) 51
sodium (43) 43
dextrose (41) 41
diabetes mellitus (38) 38
dapagliflozin (37) 37
hypoglycemic agents - therapeutic use (36) 36
endocrinology & metabolism (35) 35
male (33) 33
pharmacology & pharmacy (33) 33
sodium-glucose transporter 2 - metabolism (32) 32
hypoglycemic agents - pharmacology (28) 28
insulin (28) 28
glucose transporter (27) 27
analysis (26) 26
hyperglycemia (26) 26
double-blind (25) 25
glucose - metabolism (23) 23
rats (23) 23
blood glucose - metabolism (22) 22
female (21) 21
glucose metabolism (21) 21
glycemic control (21) 21
type 2 diabetes mellitus (21) 21
blood pressure (20) 20
diabetes mellitus, type 2 - metabolism (20) 20
clinical trials (19) 19
glucosides - therapeutic use (19) 19
hypoglycemic agents - adverse effects (19) 19
blood glucose - drug effects (18) 18
hypoglycemic agents (18) 18
inadequate glycemic control (18) 18
rodents (18) 18
sodium-glucose transporter 1 - metabolism (18) 18
medicine & public health (17) 17
review (17) 17
sglt2 inhibitor (17) 17
sglt2 inhibitors (17) 17
treatment outcome (17) 17
type-2 diabetes-mellitus (17) 17
body weight (16) 16
canagliflozin (16) 16
efficacy (16) 16
glucosides - pharmacology (16) 16
inhibitors (16) 16
blood sugar (15) 15
diabetes mellitus, type 2 - blood (15) 15
diabetes mellitus, type 2 - complications (15) 15
kidney - drug effects (15) 15
physiology (15) 15
research (15) 15
safety (15) 15
blood-pressure (14) 14
kidney (14) 14
kidney - metabolism (14) 14
proteins (14) 14
benzhydryl compounds - therapeutic use (13) 13
empagliflozin (13) 13
internal medicine (13) 13
medical research (13) 13
mice (13) 13
transporter (13) 13
diabetes mellitus, type 2 - physiopathology (12) 12
glomerular hyperfiltration (12) 12
glycosylated hemoglobin (12) 12
health aspects (12) 12
metformin (12) 12
mutation (12) 12
na+/glucose cotransporter (12) 12
risk factors (12) 12
care and treatment (11) 11
chemistry, medicinal (11) 11
diabetes therapy (11) 11
drug therapy (11) 11
kidneys (11) 11
patients (11) 11
reabsorption (11) 11
sodium-glucose transporter 2 inhibitors - therapeutic use (11) 11
type-2 (11) 11
benzhydryl compounds - pharmacology (10) 10
cardiovascular diseases (10) 10
diabetes-mellitus (10) 10
endocrinology (10) 10
glycated hemoglobin a - metabolism (10) 10
medicine (10) 10
mellitus (10) 10
middle aged (10) 10
pharmacology/toxicology (10) 10
physiological aspects (10) 10
renal function (10) 10
sglt2 (10) 10
sodium-glucose transporter 1 (10) 10
cardiovascular disease (9) 9
drugs (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, Obesity and Metabolism, ISSN 1462-8902, 06/2015, Volume 17, Issue 6, pp. 591 - 598
Aim To investigate the efficacy and safety of ertugliflozin, in a phase II dose‐ranging study, in patients with type 2 diabetes mellitus (T2DM) inadequately... 
sodium‐glucose linked co‐transporter (SGLT) | PF‐04971729 | ertugliflozin | HbA1c | type 2 diabetes mellitus (T2DM) | Sodium-glucose linked co-transporter (SGLT) | Ertugliflozin | PF-04971729 | Type 2 diabetes mellitus (T2DM) | sodium-glucose linked co-transporter (SGLT) | GLYCEMIC CONTROL | MONOTHERAPY | DAPAGLIFLOZIN | PLUS SULFONYLUREA | SITAGLIPTIN | RANDOMIZED-TRIAL | MELLITUS | CANAGLIFLOZIN | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Glycated Hemoglobin A - drug effects | Body Weight - drug effects | Male | Genital Diseases, Female - chemically induced | Dose-Response Relationship, Drug | Hypoglycemic Agents - administration & dosage | Urinary Tract Infections - chemically induced | Adult | Female | Blood Pressure - drug effects | Metformin - administration & dosage | Hypoglycemia - chemically induced | Sitagliptin Phosphate - administration & dosage | Double-Blind Method | Genital Diseases, Male - chemically induced | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | Drug Therapy, Combination - methods | Aged | Sodium-Glucose Transport Proteins - antagonists & inhibitors | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Mycoses - chemically induced | Type 2 diabetes | Complications and side effects | Medical research | Care and treatment | Mycoses | Medicine, Experimental | Hemoglobin | Urinary tract infections | Hypoglycemic agents | Glucose | Dextrose | Blood pressure | Diabetes | Glucose transporter | Sodium | Diabetes mellitus | Body weight | Urinary tract | Safety | Metformin | Hypoglycemia | Diabetes mellitus (non-insulin dependent)
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 09/2017, Volume 19, Issue 9, pp. 1322 - 1326
Journal Article
Molecular Metabolism, ISSN 2212-8778, 2012, Volume 2, Issue 1, pp. 47 - 53
Abstract Portal vein glucose sensors detect variations in glycemia to induce a nervous signal that influences food intake and glucose homeostasis. Previous... 
Endocrinology & Metabolism | Glucose metabolism | Peripheral nervous signal | Portal vein | SGLTs | Food intake | Glucose sensing | CELLS | MECHANISM | FOOD-INTAKE | INTESTINAL GLUCONEOGENESIS | SENSOR | REGULATOR | LIVER | ENDOCRINOLOGY & METABOLISM | SECRETION | VEIN | RECEPTORS
Journal Article
Journal Article
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 07/2018, Volume 20, Issue 7, pp. 1659 - 1669
Journal Article